Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

47 recalls · Class II, newest first

Class II · Moderate risk

Estriol

cGMP Deviations: lack of quality assurance at the API manufacturer.

Terminated cGMP deviation Fagron, Inc NDC 51552-1392-5 D-0079-2018
Class II · Moderate risk

Methocarbamol

CGMP Deviations: Lack of quality assurance at the API manufacturer.

Terminated cGMP deviation American Pharmaceutical Ingredients LLC D-0937-2017

Recalls by year